bioebi
Posted - 10/24/24
$CPHI $ALIM $MBIO $GNPX
bioebi
Posted - 10/23/24
$MBIO $CPHI $GNPX $ALIM CPHI: China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025.
In China, the incidence of dry eye disease is about 21%-30%, second only to myopia. According to the National Bureau of Statistics of China, the total population of the country by the end of 2023 is about 1.4 billion, and the number of dry eye disease patients in China has approached 400 million.
intratio
Posted - 2 months ago
https://www.intratio.com/stock-forecast/ALIM ALIMERA SCIENCES INC Our algorithm deduces that this equity s value will decrease quickly and is not likely to present a long-term opportunity $ALIM
intratio
Posted - 2 months ago
$ALIM ALIMERA SCIENCES INC The AI estimates that this stock s price action will lose ground in the coming days and is not likely to present a long-term opportunity
DonCorleone77
Posted - 2 months ago
$ANIP $ALIM ANI Pharmaceuticals completes acquisition of Alimera Sciences ANI Pharmaceuticals (ANIP) announced the completion of its previously announced acquisition of Alimera Sciences (ALIM). ANI continues to expect high single-digit to low double-digit accretion in 2025 adjusted non-GAAP EPS with substantial accretion thereafter. The transaction is anticipated to deliver an additional $35 - $38 million in 2025 adjusted non-GAAP EBITDA inclusive of approximately $10 million in identified cost synergies with additional EBITDA contribution expected from accelerated growth of Cortrophin Gel within ophthalmology. ANI is maintaining its 2024 guidance for the standalone Company based on continued momentum across Cortrophin Gel and Generics and plans to provide 2024 guidance for the combined Company by no later than the Company's third quarter earnings call. Under the terms of the merger agreement, ANI acquired all of the outstanding shares of Alimera for $5.50 per share. The Company also repaid $72.5 million of Alimera debt. Alimera investors received one non-tradable contingent value right representing the right to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027. ANI recently completed an offering of $316.25 million aggregate principal amount of 2.25% convertible senior notes due September 1, 2029. The Company utilized a majority of the net proceeds as well as cash from its balance sheet to repay in full its existing senior secured term loan facility. The initial conversion price of the convertible notes is $74.11 per share. Concurrent with the convertible offering, the Company used $40.6 million of the net proceeds to enter into capped call transactions. The cap price of the capped call transactions is initially $114.02 per share, which represents a premium of 100% over the last reported sale price of the Company's common stock on August 7, 2024. The capped call transactions are expected generally to reduce the potential dilution to ANI's common stock upon any conversion of the notes up to the cap price of $114.02. To fund the acquisition of Alimera, ANI entered into a new senior secured credit agreement consisting of a $325 million delayed draw term loan facility and $75 million revolving credit facility. On September 16, 2024 the Company drew the full $325 million term loan; the $75 million revolving credit facility remains un-drawn. The Company expects these capital structure changes to reduce interest expense by approximately $39 million on an annualized basis as compared to estimated interest expense that would have been incurred if the new principal amount of debt was subject to rates that would have applied under the previous debt capital structure.
tradethehalt
Posted - 2 months ago
$ALIM trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $5.54 Vol: 2.68M.
intratio
Posted - 2 months ago
ALIMERA SCIENCES INC Our network infers this company s value will have a short-term downward trend with a long-term prognosis that is neutral $ALIM
intratio
Posted - 2 months ago
$ALIM https://www.intratio.com/stock-forecast/ALIM The model lets us believe that this stock s value will decrease in the near future and has a neutral long-term outlook
basscat12
Posted - 2 months ago
$QH $ALTM $ALIM Pre-Market Gap Up, delayed, courtesy of barchart, presented with @Vegas1 to help follow the money!
DonCorleone77
Posted - 2 months ago
$ANIP $ALIM ANI Pharmaceuticals, Alimera Sciences merger to close on September 16 ANI Pharmaceuticals (ANIP) and Alimera Sciences (ALIM) jointly announced that they have scheduled the closing of their transaction pursuant to the companies' previously announced Merger Agreement for before the market opens on Monday, September 16.
DARKP00L
Posted - 2 months ago
$ALIM ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
intratio
Posted - 2 months ago
https://www.intratio.com/stock-forecast/ALIM ALIMERA SCIENCES INC The predictive model assessed that this company s value is not likely to rise soon and has no clear long-term directional perspective $ALIM
LewisDaKat
Posted - 2 months ago
$ALIM News Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement https://marketwirenews.com/news-releases/alimera-sciences-takes-legal-action-against-ani-phar-8197934577741039.html $ALIM
Norbert90
Posted - 2 months ago
$ALIM Gut punch.
DonCorleone77
Posted - 2 months ago
$ANIP $ALIM ANI says working in 'good faith' to close Alimera acquisition ANI Pharmaceuticals (ANIP) provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences (ALIM). ANI said in a statement: "We note the Alimera press release issued today. The Company continues to work in good faith toward closing of the acquisition. Any delay is a result of discussions regarding closing conditions, which the Company expects to resolve promptly." Alimera Sciences, this morning announced that it has filed a lawsuit in the Delaware Court of Chancery to compel ANI "to fulfill its contractual obligation to close the transaction."
boi0118
Posted - 2 months ago
$ALIM Is it stuck? Smh lol
RETAlerts
Posted - 2 months ago
ith a 10% gain since first being spotted on our scanner, $ALIM at 5.269 is starting to gather some serious momentum. Will this breakout continue? (15 minute delay)
RETAlerts
Posted - 2 months ago
With a 10% gain since first being spotted on our scanner, $ALIM at 5.1 is starting to gather some serious momentum. Will this breakout continue? (15 minute delay)
VrtcIl
Posted - 2 months ago
If $ALIM breaks 6, the next target is 8. Keep in mind that after it breaks over a level it should not fall below another time and stay there. Price: 5.22 Float: 46.9M Short Float: 1.3 % 💰 Dollar Volume: 1.1M ℹ️ USA | Drug Manufacturers - Specialty & Generic
ThanosOmnipotent
Posted - 2 months ago
$ALIM woo hoo
tradethehalt
Posted - 2 months ago
$ALIM trade halt (LUDP) was alerted to our Members at 2:10pm EDT. Halt price: $4.96 Vol: 4.75M.
HaltTradeAlert
Posted - 2 months ago
$ALIM Halt Time: 14:10:22 Issue Symbol: ALIM Reason Code: LUDP Last Price: $4.96 Volume: 4.8 M Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
DARKP00L
Posted - 2 months ago
$ALIM ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
MissHollandia
Posted - 2 months ago
$AILE let's breakout!!!!GAPS $SGLY $ALIM $ALLY head up!
_www_larval_com_
Posted - 2 months ago
$ALIM just reverted 3% higher to -14% (~1Mv) a few minutes ago, 09/20 options, follow for more volatility.
_www_larval_com_
Posted - 2 months ago
$WHLR 9%[23%] $RLAY -9%[-4%] $SINT -6%[-9%] $DSGN 4%[16%] $ALIM -4%[-19%] most notable movement within the first minutes of trading.
DonCorleone77
Posted - 2 months ago
$ANIP $ALIM Alimera Sciences files lawsuit against ANI Pharmaceuticals to enforce merger Alimera Sciences (ALIM) announced that it has filed a lawsuit in the Delaware Court of Chancery to compel ANI Pharmaceuticals (ANIP) to fulfill its contractual obligation to close the transaction contemplated by the companies' previously announced agreement and plan of merger dated June 21, following Alimera shareholders' approval of the transaction on September 4. Alimera issued the following statement: "Alimera has fulfilled all its requirements to close the Merger Agreement, yet ANI has failed to adhere to its obligation to close on time. We believe the merger offers compelling value for our shareholders and remain focused on completing the transaction. Accordingly, we are committed to taking all actions necessary to ensure that happens. We are confident we will prevail in the Delaware Court of Chancery and look forward to consummating the merger of our companies."
DARKP00L
Posted - 2 months ago
$ALIM Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement
